Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Thrombocytopenic Clinical Trials

A listing of Thrombocytopenic medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (3) clinical trials

Patients are needed to participate in a clinical research study for the treatment of Thrombocytopenia, Pancytopenia, Neutropenia, Hematologic Malignancy, Anemia

This protocol is designed for screening of subjects before a decision can be made as to their eligibility for one of the active Hematology Branch research protocols. Its purpose is to allow detailed investigation into the hematologic or oncologic problems of these subjects, and the status of other organ systems ...

Phase N/A

A clinical trial sponsored by OHSU Knight Cancer Institute for a research study for the treatment of Richter Syndrome, Waldenstrom's Macroglobulinemia, MALT Lymphoma, Night Sweats, Thrombocytopenia, Lymphadenopathy, Refractory Small Lymphocytic Lymphoma, Weight Loss, B-cell prolymphocytic leukemia, Refractory Chronic Lymphocytic Leukemia, Splenomegaly, Fever, Lymphocytosis, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Grade 3a Follicular Lymphoma, Fatigue, follicular lymphoma, Anemia, Mantle cell lymphoma, Hairy Cell Leukemia

PRIMARY OBJECTIVES: I. To evaluate the safety and tolerability of entospletinib administered in combination with obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and non-Hodgkin lymphoma (NHL), and identify the dose for phase 2 expansion. (Phase I) II. To evaluate the efficacy of entospletinib in combination with ...


Patients are needed to participate in a clinical research study for the treatment of Thrombocytopenia, Fibrosis, Cirrhosis

This protocol will provide access to TheraSphere treatment for patients who have refractory thrombocytopenia secondary to cirrhosis. This protocol will utilize splenic artery-directed TheraSphere treatment.

Phase N/A